Hamlet Pharma

Dr Parker received a PhD in 1998 from the Medical Faculty, Lund University, Sweden. More recently, she has served as Director of Business Development at the Immunotherapy company Macrophage Pharma, Business development executive at the development and commercialization arm of Cancer Research UK (CRUK) and Non-Executive Board Director of Azeria Ltd and Arquer diagnostics Ltd.

This recruitment strengthens the business development process of Hamlet BioPharma and adds high profile pharma competence and active international networks, says Catharina Svanborg, CEO of Hamlet BioPharma.
 

For more information, please contact:

Catharina Svanborg, CEO.

Phone: +46 709 42 65 49

E-mail: catharina.svanborg@hamletbiopharm